- By insider

Chairman and CEO of Icu Medical Inc (30-Year Financial, Insider Trades) Vivek Jain (insider trades) sold 11,500 shares of ICUI on 11/06/2020 at an average price of $195 a share. The total sale was $2.2 million.

• Warning! GuruFocus has detected 5 Warning Signs with ICUI. Click here to check it out.

• ICUI 15-Year Financial Data

• The intrinsic value of ICUI

• Peter Lynch Chart of ICUI

ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others. ICU Medical Inc has a market cap of $4.12 billion; its shares were traded at around $196.13 with a P/E ratio of 51.89 and P/S ratio of 3.35. ICU Medical Inc had annual average EBITDA growth of 5.20% over the past ten years. GuruFocus has detected 3 severe warning signs with ICU Medical Inc. .

CEO Recent Trades:

• Chairman and CEO Vivek Jain sold 11,500 shares of ICUI stock on 11/06/2020 at the average price of $195. The price of the stock has increased by 0.58% since.

Directors and Officers Recent Trades:

• Director Robert S Swinney sold 277 shares of ICUI stock on 10/16/2020 at the average price of $202.22. The price of the stock has decreased by 3.01% since.

For the complete insider trading history of ICUI, click here

.This article first appeared on GuruFocus.